The sphere of thoracic and cardiothoracic surgical treatment is increasing rapidly, driven by breakthrough advancements in robotic-assisted surgeries, minimally invasive lung cancer interventions, and ground breaking cardiac valve therapies. For B2B corporations—starting from specialised surgical instrument makers and advanced imaging software pa